Jamal Tazi

8.5k total citations
87 papers, 6.0k citations indexed

About

Jamal Tazi is a scholar working on Molecular Biology, Virology and Oncology. According to data from OpenAlex, Jamal Tazi has authored 87 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 10 papers in Virology and 10 papers in Oncology. Recurrent topics in Jamal Tazi's work include RNA Research and Splicing (55 papers), RNA modifications and cancer (28 papers) and RNA and protein synthesis mechanisms (25 papers). Jamal Tazi is often cited by papers focused on RNA Research and Splicing (55 papers), RNA modifications and cancer (28 papers) and RNA and protein synthesis mechanisms (25 papers). Jamal Tazi collaborates with scholars based in France, United States and Canada. Jamal Tazi's co-authors include Stefan Stamm, Claude Brunel, Hélène Tourrière, Karim Chébli, Emmanuel Labourier, Guy Cathala, Édouard Bertrand, Johann Soret, Philippe Jeanteur and John Mouaikel and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jamal Tazi

85 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamal Tazi France 43 5.3k 511 497 457 306 87 6.0k
Yegor Vassetzky France 35 2.7k 0.5× 310 0.6× 456 0.9× 404 0.9× 271 0.9× 160 3.4k
Giuseppe Biamonti Italy 47 5.5k 1.0× 688 1.3× 525 1.1× 445 1.0× 156 0.5× 114 6.3k
Stéphan Vagner France 41 4.9k 0.9× 797 1.6× 820 1.6× 381 0.8× 154 0.5× 86 5.8k
Anton A. Komar United States 40 4.9k 0.9× 368 0.7× 386 0.8× 618 1.4× 195 0.6× 110 5.9k
Richard A. Padgett United States 38 6.9k 1.3× 421 0.8× 373 0.8× 758 1.7× 335 1.1× 72 7.9k
Rolf Marschalek Germany 40 3.3k 0.6× 412 0.8× 569 1.1× 397 0.9× 470 1.5× 225 5.4k
Hervé Le Hir France 39 6.4k 1.2× 395 0.8× 180 0.4× 380 0.8× 146 0.5× 68 6.9k
David Maag United States 27 2.7k 0.5× 506 1.0× 1.3k 2.6× 471 1.0× 135 0.4× 57 4.6k
Scott Briggs United States 32 6.1k 1.1× 224 0.4× 456 0.9× 489 1.1× 104 0.3× 50 6.9k
Hong Sun China 30 3.2k 0.6× 505 1.0× 189 0.4× 358 0.8× 129 0.4× 77 4.2k

Countries citing papers authored by Jamal Tazi

Since Specialization
Citations

This map shows the geographic impact of Jamal Tazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Tazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Tazi more than expected).

Fields of papers citing papers by Jamal Tazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal Tazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Tazi. The network helps show where Jamal Tazi may publish in the future.

Co-authorship network of co-authors of Jamal Tazi

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal Tazi. A scholar is included among the top collaborators of Jamal Tazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal Tazi. Jamal Tazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bron, Patrick, et al.. (2024). P025 Obefazimod and its active metabolites ABX-464-N-Glu act by stabilizing protein-protein interaction among key RNA biogenesis partners, CBC and ARS2. Journal of Crohn s and Colitis. 18(Supplement_1). i276–i276. 1 indexed citations
2.
Tourrière, Hélène, Karim Chébli, Brice Courselaud, et al.. (2023). The RasGAP-associated endoribonuclease G3BP mediates stress granule assembly. The Journal of Cell Biology. 222(11). 22 indexed citations
3.
Toledo, Marion de, et al.. (2020). Modulation of Yorkie activity by alternative splicing is required for developmental stability. The EMBO Journal. 40(3). 7 indexed citations
4.
Scherrer, Didier, Roman Rouzier, Perry Barrett, et al.. (2016). Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects. Journal of Antimicrobial Chemotherapy. 72(3). dkw458–dkw458. 14 indexed citations
5.
López‐Mejía, Isabel C., Marion de Toledo, Flavio Della Seta, et al.. (2013). Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion. Molecular Biology of the Cell. 24(20). 3164–3176. 19 indexed citations
6.
Venables, J. P., Laure Lapasset, Gilles Gadéa, et al.. (2013). MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nature Communications. 4(1). 2480–2480. 105 indexed citations
7.
Dutertre, Martin, Magali Lacroix‐Triki, Keltouma Driouch, et al.. (2010). Exon-Based Clustering of Murine Breast Tumor Transcriptomes Reveals Alternative Exons Whose Expression Is Associated with Metastasis. Cancer Research. 70(3). 896–905. 53 indexed citations
8.
Keriel, Anne, Florence Mahuteau‐Betzer, Chantal Jacquet, et al.. (2009). Protection against Retrovirus Pathogenesis by SR Protein Inhibitors. PLoS ONE. 4(2). e4533–e4533. 16 indexed citations
9.
Tazi, Jamal, et al.. (2008). Alternative splicing and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(1). 14–26. 402 indexed citations
10.
Baldin, Véronique, Y. Thomas, Christine Doucet, et al.. (2008). A Novel Role for PA28γ-Proteasome in Nuclear Speckle Organization and SR Protein Trafficking. Molecular Biology of the Cell. 19(4). 1706–1716. 50 indexed citations
11.
Tournier, Isabelle, Myriam Vézain, Alexandra Martins, et al.. (2008). A large fraction of unclassified variants of the mismatch repair genesMLH1andMSH2is associated with splicing defects. Human Mutation. 29(12). 1412–1424. 126 indexed citations
12.
Juge, François, et al.. (2007). Eye Development under the control of SRp55/B52-Mediated Alternative Splicing of eyeless. PLoS ONE. 2(2). e253–e253. 17 indexed citations
13.
Lin, Yea‐Lih, Lilia Ayadi, Florence Mahuteau‐Betzer, et al.. (2007). Small-Molecule Inhibition of HIV pre-mRNA Splicing as a Novel Antiretroviral Therapy to Overcome Drug Resistance. PLoS Pathogens. 3(10). e159–e159. 71 indexed citations
14.
Soret, Johann, Mathieu Gabut, & Jamal Tazi. (2006). SR Proteins as Potential Targets for Therapy. Progress in molecular and subcellular biology. 44. 65–87. 24 indexed citations
15.
Gabut, Mathieu, et al.. (2005). The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1α Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis. Molecular and Cellular Biology. 25(8). 3286–3294. 55 indexed citations
16.
Tourrière, Hélène, Imed‐Eddine Gallouzi, Karim Chébli, et al.. (2001). RasGAP-Associated Endoribonuclease G3BP: Selective RNA Degradation and Phosphorylation-Dependent Localization. Molecular and Cellular Biology. 21(22). 7747–7760. 163 indexed citations
17.
Labourier, Emmanuel, Jean‐François Riou, Michelle Prudhomme, et al.. (1999). Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.. PubMed. 59(1). 52–5. 27 indexed citations
18.
19.
Labourier, Emmanuel, Imed‐Eddine Gallouzi, Jean Derancourt, et al.. (1998). The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity. Nucleic Acids Research. 26(12). 2963–2970. 41 indexed citations
20.
Daugeron, Marie‐Claire, et al.. (1992). U1—U2 snRNPs interaction induced by an RNA complementary to the 5′ end sequence of U1 snRNA. Nucleic Acids Research. 20(14). 3625–3630. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yegor Vassetzky Breakdown of academic impact, for papers by Giuseppe Biamonti Breakdown of academic impact, for papers by Stéphan Vagner Breakdown of academic impact, for papers by Anton A. Komar Breakdown of academic impact, for papers by Richard A. Padgett Breakdown of academic impact, for papers by Rolf Marschalek Breakdown of academic impact, for papers by Hervé Le Hir Breakdown of academic impact, for papers by David Maag Breakdown of academic impact, for papers by Scott Briggs Breakdown of academic impact, for papers by Hong Sun
Rankless by CCL
2026